Condition: Cervical Disc Degenerative Disorder · Sponsor: NuVasive
The purpose of the study is to evaluate the safety and effectiveness of the NeoDisc compared to anterior cervical discectomy and fusion (ACDF) for the treatment of single-level cervical disc disease, by demonstrating non-inferior comparative results at the 24 month follow-up period pertaining to (1) improvement in the Neck Disability Index (NDI) score, (2) revision/reoperation/removal rate, (3) complication rate, and (4) maintenance or improvement in neurologic status.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| San Diego Center for Spinal Disorders | La Jolla, California, United States | — |
| Diagnostic and Interventional Surgical Center | Marina del Rey, California, United States | — |
| The Spine Institute | Santa Monica, California, United States | — |
| Spine Colorado / Durango Orthopedic Associates | Durango, Colorado, United States | — |
| Rocky Mountain Spine Arthroplasty (RMA Ortho) | Loveland, Colorado, United States | — |
| Florida Spine Specialists | Fort Lauderdale, Florida, United States | — |
| Florida Research Network, LLC | Gainesville, Florida, United States | — |
| Lyerly Baptist | Jacksonville, Florida, United States | — |
| Optim Healthcare | Savannah, Georgia, United States | — |
| OAD Orthopaedics | Warrenville, Illinois, United States | — |
| OrthoIndy | Indianapolis, Indiana, United States | — |
| Spine Midwest, Inc | Jefferson City, Missouri, United States | — |
+ 10 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.